Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. (GLSI) Insider Trading
Directors, officers and holders of more than 10% of GLSI report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 35 most recent of 35 transactions on file: 27 with code P, 0 with code S and 8 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Patel Snehal | CEO and CFO | P Purchase | 700 | $13.10 | $9,170 |
| Jul 28, 2026 | Patel Snehal | CEO and CFO | P Purchase | 1,500 | $13.59 | $20,385 |
| Jul 27, 2026 | Patel Snehal | CEO and CFO | P Purchase | 1,500 | $13.62 | $20,430 |
| Jul 24, 2026 | Patel Snehal | CEO and CFO | P Purchase | 1,100 | $12.88 | $14,168 |
| Jul 23, 2026 | Patel Snehal | CEO and CFO | P Purchase | 2,500 | $13.14 | $32,850 |
| Jan 13, 2026 | Patel Snehal | CEO and CFO | P Purchase | 1,800 | $29.83 | $53,694 |
| Jan 12, 2026 | Patel Snehal | CEO and CFO | P Purchase | 2,900 | $27.54 | $79,866 |
| Dec 31, 2025 | Patel Snehal | CEO and CFO | P Purchase | 4,300 | $21.36 | $91,848 |
| Dec 30, 2025 | Patel Snehal | CEO and CFO | P Purchase | 2,900 | $21.73 | $63,017 |
| Dec 18, 2025 | Patel Snehal | CEO and CFO | P Purchase | 4,100 | $12.62 | $51,742 |
| Nov 25, 2025 | Patel Snehal | CEO and CFO | P Purchase | 4,600 | $8.37 | $38,502 |
| Nov 13, 2025 | Patel Snehal | CEO and CFO | A Award | 100,000 | Not measured | Not measured |
| Nov 7, 2025 | Patel Snehal | CEO and CFO | P Purchase | 10,600 | $8.43 | $89,358 |
| Oct 31, 2025 | Patel Snehal | CEO and CFO | P Purchase | 2,300 | $9.26 | $21,298 |
| Apr 25, 2025 | Patel Snehal | CEO and CFO | P Purchase | 3,600 | $9.88 | $35,568 |
| Apr 17, 2025 | Patel Snehal | CEO and CFO | P Purchase | 5,400 | $8.98 | $48,492 |
| Apr 7, 2025 | Patel Snehal | CEO and CFO | P Purchase | 3,600 | $9.10 | $32,760 |
| Apr 4, 2025 | Patel Snehal | CEO and CFO | P Purchase | 5,500 | $8.73 | $48,015 |
| Jan 10, 2025 | Patel Snehal | CEO and CFO | P Purchase | 2,500 | $12.51 | $31,275 |
| Jan 7, 2025 | Patel Snehal | CEO and CFO | P Purchase | 1,800 | $13.75 | $24,750 |
| Jan 6, 2025 | Patel Snehal | CEO and CFO | P Purchase | 1,100 | $13.31 | $14,641 |
| Jan 3, 2025 | Patel Snehal | CEO and CFO | P Purchase | 3,400 | $12.95 | $44,030 |
| Jan 2, 2025 | Patel Snehal | CEO and CFO | P Purchase | 2,000 | $11.97 | $23,940 |
| Dec 31, 2024 | Patel Snehal | CEO and CFO | P Purchase | 2,400 | $11.36 | $27,264 |
| Dec 30, 2024 | Patel Snehal | CEO and CFO | P Purchase | 3,200 | $11.12 | $35,584 |
| Dec 24, 2024 | McWilliams David | Director | A Award | 61,984 | Not measured | Not measured |
| Dec 24, 2024 | Patel Snehal | CEO and CFO | A Award | 1,148,723 | Not measured | Not measured |
| Dec 24, 2024 | Patel Snehal | CEO and CFO | A Award | 25,008 | Not measured | Not measured |
| Dec 24, 2024 | Rothe Eric | Director | A Award | 41,349 | Not measured | Not measured |
| Dec 24, 2024 | Thompson Jaye | VP Clinical Reg Affairs | A Award | 149,818 | Not measured | Not measured |
| Dec 24, 2024 | Hallock Kenneth | Director | A Award | 41,349 | Not measured | Not measured |
| Dec 24, 2024 | Daugherty Frank Joseph | Chief Medical Officer | A Award | 104,890 | Not measured | Not measured |
| Nov 21, 2024 | Thompson Jaye | VP Clinical Reg Affairs | P Purchase | 1,000 | $12.91 | $12,910 |
| Sep 26, 2024 | Patel Snehal | CEO and CFO | P Purchase | 1,500 | $14.63 | $21,945 |
| Aug 12, 2024 | Thompson Jaye | VP Clinical Reg Affairs | P Purchase | 800 | $13.85 | $11,080 |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.